06.04.26 -- Next-Gen Precision Control For Cell Therapy Workflows

Closed, automated T cell isolation with greater than 85% efficiency and greater than 96% purity is now achievable in 70 to 100 minutes, with cGMP-ready scalability.

Enzymatically synthesized DNA is assessed as a plasmid alternative, showing comparable viral vector yield, quality, and purification, while improving scalability and regulatory flexibility.

Animal‑free raw materials offer adjustable attributes, controlled manufacturing, and consistent nutrient profiles, ensuring reliable performance and customizable solutions across multiple processes.

Learn how extended transfection stability windows and reduced complex volumes solve critical scale-up challenges in AAV and lentivirus manufacturing at 1000+ liter production scales.

See how a rapid digital PCR workflow enables reliable detection of trace RCL levels while maintaining strong performance in complex samples, which support more confident decisions in manufacturing.

Simplify cell retention with flexible single-use or stainless steel formats. Enhance high-impact upstream applications, including N-1 perfusion, seed train intensification, and high-yield harvest.

Discover how digital transformation drives efficiency, agility, and compliance in pharmaceutical manufacturing to optimize processes, improve quality, and accelerate time-to-market.

This programmable incubator ensures temperature uniformity from -10°C to +60°C. Microprocessor controls support reliable stability testing, microbiology, and plant cell culture applications.

Optimize your workflow with high-throughput sample processing and automated dilution. Long-term reagent stability and 96-well integration improve measurement accuracy and minimize manual labor.

CGT developers and researchers no longer have to rely on a highly manual and variable process. Now they can finish strong with precise, consistent results for suspension cells and adherent cells.

This flexible fluid dispensing platform utilizes fully disposable fluid paths. It accommodates diverse sterile connection options to support secure filtration and single-use bag filling.

View this strategic program for CGT innovators that offers access to advanced technologies, GMP-grade tools, and expert support to accelerate progress from research to clinical-scale manufacturing.

Review the primary packaging and continuity challenges companies face during the transition to commercialization. Prepare early-stage production pipelines for a successful commercial launch.